University of Texas at Houston   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Houston TX United States (1972)

Organization Overview

First Clinical Trial
1984
NCT03164291
First Marketed Drug
2013
sodium fluoride-18f
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now